• New Research and Pipeline Updates at Alzheimer’s Conference

    Bio-IT World | The Alzheimer's Association International Conference was held last week in Toronto and researchers and companies gathered to present their progress in the fight to diagnose and treat Alzheimer’s disease. Among the timely new developments: new products from Quanterix; pre-clinical data from AltPep, OncoC4, and NKGen Biotech; pipeline updates from Eisai, Biogen, and Roche; and more.

    Aug 6, 2025

  • XProteome Launches with AI-Powered Protein Corona Platform for Disease Detection

    Bio-IT World | A new biotech company launched last month with a novel approach to protein discovery that could transform how researchers identify biomarkers and develop treatments for cardiovascular disease, cancer, and neurodegenerative conditions. XProteome, founded by Michigan State University researcher Morteza Mahmoudi, has developed an integrated platform that combines nanomedicine, artificial intelligence, and causality analysis to pinpoint disease-causing proteins with unprecedented precision.

    Aug 5, 2025

  • Longitude Prize on ALS Launches, UK Biobank Completes World’s Largest Whole Body Imaging Project, More

    Bio-IT World | The Longitude Prize on ALS, presented at this year’s Bio-IT World Conference & Expo, has launched to incentivize and reward cutting edge AI-based approaches to transform drug discovery for the treatment of ALS (amyotrophic lateral sclerosis); UK Biobank completed the world’s largest whole body imaging project; and more.

    Jul 31, 2025

  • Follow the Money: Universal Flu Vaccine, Full-Length Single-Molecule Protein Sequencer, More

    Bio-IT World | Centivax plans to get their first universal flu vaccine through a Phase I clinical trial; Portal Biotech will use their nanopore-based platform technology to deliver rapid, full-length, single-molecule protein characterization and expand its R&D, engineering, and data-science teams; and more.

    Jul 30, 2025